GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Johnson Pharmacare Ltd

Johnson Pharmacare FY26 Audited Results: Qualified Opinion Issued

RESULTS ▼ Concern Flagged HIGH RISK
📅 Filed on BSE: 27 May 2026, 07:52 PM IST  ·  BSE ID: 90bc0577-225c-4fa0-b1de-17fb0d0cbdd0
View Original BSE Filing (PDF)
💡
In Simple Terms
The company released its full-year financial report, but its auditors flagged concerns about unpaid loan interest and how loans were handled.
🤖 AI Summary
  • Johnson Pharmacare Ltd. filed audited financial results for FY26 and Q4 FY26.
  • Statutory Auditors M/S V R S K & ASSOCIATES issued a qualified opinion on the results.
  • Auditors cited non-provision of interest on loans and non-compliance with IND-AS.
  • Balance of borrowed loans stood at Rs. 2140.04 Lakhs as of March 31, 2026.
  • Fair valuation of unquoted instruments was a key audit matter due to unavailable independent reports.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Balance of borrowed loans as of March 31, 2026
Rs. 2140.04 Lakhs
🏢 How This Affects the Company
💰
Financial Impact
The qualified audit opinion and noted issues regarding loan interest provision could impact the reported financial performance and true state of affairs.
⚠️
Risk Impact
The qualified audit opinion and non-compliance with IND-AS introduce significant regulatory and financial reporting risk for the company.
👥 What This Means For Shareholders
✅
Action Required
Shareholders should review the audit report and management's response for clarity on the qualified opinion and noted financial matters.
👤
Who Is Affected
All shareholders are affected as the qualified opinion indicates potential inaccuracies in the reported financial position and performance for FY26.
🔍
Management Signal
Management submitted the results despite the qualified opinion, indicating adherence to regulatory disclosure timelines.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Company's response to the qualified audit opinion and identified issues.
Specific steps management plans to take regarding IND-AS compliance.
Details on the terms and status of the Rs. 2140.04 Lakhs in borrowed loans.
HIGH RISK Qualified audit opinion, non-compliance with IND-AS, and significant concerns over borrowed loan accounting present high financial reporting risk.
💡 Investor Takeaway
Johnson Pharmacare Ltd.'s FY26 audited results received a qualified opinion from auditors. Key concerns included non-provision of interest on loans, a borrowed loan balance of Rs. 2140.04 Lakhs, and non-compliance with IND-AS.
⚖️ Strengths & Concerns

⚠️ Concerns

  • Auditors issued a qualified opinion, stating financial statements 'may not give a true and fair view' due to non-provision of interest on loans.
  • The company's balance of borrowed loans was Rs. 2140.04 Lakhs as of March 31, 2026, with audit concerns regarding terms and conversion to equity.
📅 Company Track Record
A past filing from 2026-05-27 also noted auditors issued a qualified opinion on Johnson Pharmacare's FY26 results, citing Rs. 2140.04 Lakhs in borrowed loans.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What is the key issue identified in Johnson Pharmacare's FY26 audit report?
The auditors issued a qualified opinion due to the non-provision of interest on loans, stating the financial statements may not give a true and fair view.
What was the balance of borrowed loans for Johnson Pharmacare as of March 31, 2026?
As of March 31, 2026, the company had a balance of borrowed loans amounting to Rs. 2140.04 Lakhs.
Did Johnson Pharmacare Ltd. comply with Indian Accounting Standards (IND-AS) for FY26?
The auditors noted that Johnson Pharmacare Ltd. should have prepared its financial statements in compliance with IND-AS, indicating non-compliance.
What was a key audit matter regarding investments for Johnson Pharmacare in FY26?
Fair valuation of investments in unquoted instruments was a key audit matter, with independent valuation reports reportedly unavailable for the auditors' consideration.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.